Picture credit: ATU Photographs/Getty Photographs
Dubai’s Gulf Islamic Investments (GII) has agreed to accumulate a big fairness stake in Saudi Arabia’s Abeer Medical Firm (Abeer) in a deal value an estimated SAR600 million, the most recent within the kingdom’s booming healthcare sector.
With $4 billion in belongings underneath administration, GII’s development technique for Abeer consists of increasing the variety of hospitals and clinics, along with rolling out further manufacturers to broaden the healthcare supplier’s attain and geographic footprint.
“The funding from GII will allow us to spice up Abeer Medical Firm’s community of 14 medical facilities and two common hospitals – all with clinics – with a mixture of natural development acquisitions and investments in new healthcare amenities,” mentioned Mohammed Alungal, Abeer’s President & CEO,
“This can be a very thrilling improvement for the healthcare panorama in Saudi Arabia. Abeer will proceed to pioneer its dedication to delivering inexpensive high quality healthcare,” because the group celebrates its twenty fifth anniversary.e anniversary this yr.”
The deal will increase GII’s Saudi healthcare portfolio, which already features a majority stake within the AlMeswak chain of dental and dermatology clinics.
The partnership of GII and Abeer’s established healthcare community of hospitals, clinics, pharmacies and optical hospitals in six cities in Saudi Arabia gives ample alternatives to broaden healthcare companies within the kingdom.
Abeer operates roughly 50 healthcare amenities, together with hospitals, pharmacies and clinics in Saudi Arabia and the Arabian Gulf area.
GII faucets into Saudi Arabia’s thriving healthcare sector
In the meantime, GII’s acquisition of a SAR600 million stake in Abeer comes at a time when the Saudi healthcare sector has attracted extra funding as the dominion undertakes a plan to spice up personal sector participation within the sector.
Saudi pharmaceutical big Center East Pharmaceutical Industries Firm, also called Avalon Pharma, final Friday set the worth for its deliberate preliminary public providing (IPO) on the Saudi Trade.
Saudi pharmaceutical big Center East Pharmaceutical Industries Firm, also called Avalon Pharma, has set the worth for its deliberate preliminary public providing (IPO) on the Saudi Trade.
Avalon Pharma set the worth vary for the providing between SAR78 – 82 per share.
Equally, generic drug maker Jamjoom Prescribed drugs Manufacturing unit Firm raised $335 million in an preliminary public providing final yr and its shares have since doubled.
